Search research articles
Contact Us
Filters
Showing results (121-130 of 140) with videos related to
Page
of 14
Sort By:
Journal of Medicinal Chemistry
|
May 17, 2008
Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII
Katia D'Ambrosio, Rosa-Maria Vitale, Jean-Michel Dogné, et al.
Bioorganic & Medicinal Chemistry
|
September 8, 2007
Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity
Mohammed K Abdel-Hamid, Atef A Abdel-Hafez, Nawal A El-Koussi, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 30, 2004
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties
Vladimir Garaj, Luca Puccetti, Giuseppe Fasolis, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 16, 2010
Inhibition of the R1 fragment of the cadmium-containing zeta-class carbonic anhydrase from the diatom Thalassiosira weissflogii with anions
Francesca Viparelli, Simona Maria Monti, Giuseppina De Simone, et al.
Bioorganic & Medicinal Chemistry
|
February 2, 2011
Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site
Serdar Durdagi, Murat Şentürk, Deniz Ekinci, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 21, 2005
Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX
Vladimir Garaj, Luca Puccetti, Giuseppe Fasolis, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 25, 2005
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates
Jean-Yves Winum, Silvia Pastorekova, Lydia Jakubickova, et al.
Journal of Medicinal Chemistry
|
November 28, 2006
Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue
Jean-Yves Winum, Claudia Temperini, Khaled El Cheikh, et al.
Bioorganic & Medicinal Chemistry
|
February 29, 2012
Design and synthesis of thiourea compounds that inhibit transmembrane anchored carbonic anhydrases
Janina Moeker, Kanae Teruya, Sabine Rossit, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
April 25, 2009
Novel organometallic cationic ruthenium(II) pentamethylcyclopentadienyl benzenesulfonamide complexes targeted to inhibit carbonic anhydrase
Bradley T Loughrey, Michael L Williams, Peter C Healy, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 140) with videos related to
Sort By:
Page
of 14
Journal of Medicinal Chemistry
|
May 17, 2008
Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII
Katia D'Ambrosio, Rosa-Maria Vitale, Jean-Michel Dogné, et al.
Bioorganic & Medicinal Chemistry
|
September 8, 2007
Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity
Mohammed K Abdel-Hamid, Atef A Abdel-Hafez, Nawal A El-Koussi, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 30, 2004
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties
Vladimir Garaj, Luca Puccetti, Giuseppe Fasolis, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 16, 2010
Inhibition of the R1 fragment of the cadmium-containing zeta-class carbonic anhydrase from the diatom Thalassiosira weissflogii with anions
Francesca Viparelli, Simona Maria Monti, Giuseppina De Simone, et al.
Bioorganic & Medicinal Chemistry
|
February 2, 2011
Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site
Serdar Durdagi, Murat Şentürk, Deniz Ekinci, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 21, 2005
Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX
Vladimir Garaj, Luca Puccetti, Giuseppe Fasolis, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 25, 2005
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates
Jean-Yves Winum, Silvia Pastorekova, Lydia Jakubickova, et al.
Journal of Medicinal Chemistry
|
November 28, 2006
Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue
Jean-Yves Winum, Claudia Temperini, Khaled El Cheikh, et al.
Bioorganic & Medicinal Chemistry
|
February 29, 2012
Design and synthesis of thiourea compounds that inhibit transmembrane anchored carbonic anhydrases
Janina Moeker, Kanae Teruya, Sabine Rossit, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
April 25, 2009
Novel organometallic cationic ruthenium(II) pentamethylcyclopentadienyl benzenesulfonamide complexes targeted to inhibit carbonic anhydrase
Bradley T Loughrey, Michael L Williams, Peter C Healy, et al.
Page
of 14